Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades Amryt Pharma to Hold

Maxim Group Downgrades Amryt Pharma to Hold

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.

byBenzinga Newsdesk

January 10, 2023

1 minute read

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.

TELA Bio Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

By Happy Mohamed

April 18, 4:11 PM

TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and

TELA

Analyst Ratings

Expert Ratings for Alexandria Real Estate

By Benzinga Insights

June 12, 10:04 AM

Over the past 3 months, 7 analysts have published their opinion on Alexandria Real Estate (NYSE:ARE) stock. These…

ARE

Shell’s Hydrogen Exit In California Deals A Major Blow To State’s Green Mobility Drive

By Benzinga Neuro

February 12, 7:12 AM

Shell's decision is a significant blow to the struggling hydrogen fuel cell passenger technology in California and the broader U.S. market.

SHEL

Will The Ethereum Merge Bring Back The Bulls — Or Is It A Trap?

By Shiv Juneja

July 21, 10:43 AM

Ethereum (CRYPTO: ETH) has seen a tremendous upswing in price action over the last week.

BTC

Maxim Group Downgrades Amryt Pharma to Hold

Related Posts

TELA Bio Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

Expert Ratings for Alexandria Real Estate

Shell’s Hydrogen Exit In California Deals A Major Blow To State’s Green Mobility Drive

Will The Ethereum Merge Bring Back The Bulls — Or Is It A Trap?